Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Neuropharmacology. 2017 Aug 2;125:272–283. doi: 10.1016/j.neuropharm.2017.07.033

Figure 1.

Figure 1

Experimental design schematics for (A) short-term abstinence from chronic nicotine, (B) long-term abstinence from chronic nicotine, and (C) FLX treatment during long-term abstinence from adolescent chronic nicotine exposure.